OncoBriefs: Myeloma, Bone Markers, CT Scans
(MedPage Today) -- Patients with multiple myeloma had an increased risk of second hematologic malignancies when treated with the combination of lenalidomide and melphalan, authors of a meta-analysis concluded.
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news
More News: Cancer & Oncology | CT Scan | Gastroenterology | Hematology | Myeloma | PET Scan | Revlimid